0
Article |

The Background of Chemotherapy of Virus Diseases.

JOHN S. WALKER, MD
Am J Dis Child. 1965;109(2):183-184. doi:10.1001/archpedi.1965.02090020185025.
Text Size: A A A
Published online

ABSTRACT

This small book offers a brief and understandable resumé of the progress in the field of viral chemotherapy. The authors state in the introduction that its content will be familiar to virologists but they hope "it will be useful to those who seek to understand why progress against the viruses is apparently so slow." The first chapter is a brief summary of the present understanding of the chemical composition and multiplication of viruses; this is followed by chapters on the pathology of viral infections, Interferon and virus interference, experimental chemotherapy, evaluation of chemotherapy in human infections, and a final chapter on the treatment of secondary bacterial infections.

In the chapter on assessment of chemotherapy in human infections the reported studies with 5-iodo-2-deoxyuridine (IUDR), N-methylisatin-β-thiosemicarbazone and N'N'-anhydrobis-(β-hydroxyethyl) biguanide hydrochloride (ABOB) are nicely summarized. The authors point out the necessity of rigorously controlled clinical trials, especially in the relatively mild, self-limited viral

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();